Validation, Commissioning & Design Featured Articles

  1. What Is A Bowie-Dick Test And Why Is It Important? 5/28/2025

    Effective sterilization is vital in pharma and medical device manufacturing. Discover how the Bowie-Dick test ensures vacuum sterilizer performance, safeguards patient safety, and strengthens your sterility assurance program.

  2. Understanding D-values: A Simplified Explanation For Busy Professionals 5/28/2025

    D-values are essential for ensuring sterility in pharma and medical device manufacturing. Explore a simplified concept that helps professionals optimize sterilization processes and ensure product safety with confidence.

  3. Top 3 Mistakes Companies Make During Sterilization Validation 5/27/2025

    Sterilization validation is essential for product safety and compliance. Discover the top three mistakes companies make and learn practical strategies to avoid delays, non-compliance, and patient safety risks.

  4. The Ultimate Guide To Biological Indicators 5/27/2025

    Discover why biological indicators are the gold standard for sterilization validation in pharmaceutical and medical device manufacturing, as well as how choosing the right one ensures safety, compliance, and product integrity.

  5. 5 Biggest Sterilization Challenges Facing Manufacturers 5/27/2025

    Sterility is non-negotiable in pharmaceutical and medical device manufacturing. Discover the top five sterilization challenges facing manufacturers today and the proven strategies to overcome them while ensuring compliance and safety.

  6. What Patients Say Matters: How AI Analyzes Sentiment to Improve Generic Drug Oversight 5/22/2025

    Employing multiple AI models to analyze public sentiment of generic drugs minimizes bias and enhances reliability. This makes AI a proactive tool for pharmaceutical quality assurance.

  7. Responding To Fill-Finish And Automation Scale-Up Challenges 5/21/2025

    Behind every life-saving cell therapy is a complex manufacturing journey. Examine the critical role of automation in overcoming production challenges and ensuring quality.

  8. Why Biotech Leaders Can't Afford Delays In Document Review 5/15/2025

    Document review is a hidden bottleneck in biopharma. Learn how inefficiencies in this critical process can delay drug development and what you can do to accelerate time to market.

  9. The 3 Phases of QRM – An Inspector's View 5/14/2025

    Quality resource management has three phases: assessment, control, and review. The experts at GMP Compliance Advisor bring us this breakdown of all of them.

  10. Addressing Human "Error" In Pharma Manufacturing 5/7/2025

    Why is it that managers at pharma manufacturing sites continue to be frustrated by what could be labeled as “avoidable” human errors, and what can companies do about it? Let's investigate.